LLY

Eli Lilly & Co
D

LLY

Arincen80/100B

Eli Lilly & Co EPS (earnings per share) 1985–2026

Eli Lilly & Co's diluted EPS in Q3 FY2026, the three months to 30 September 2026, was 7.22 USD, up 16.3% on the same quarter a year before. Eli Lilly & Co's diluted earnings per share over the last twelve months were 30.81 USD, up 50.7% on the twelve months before. In fiscal year 2025 they were 22.95 USD, up 96.0% on the year before.

Last updated 10 Nov 2026 · Next report 3 Feb 2027

EPS

Growth

Fiscal yearPeriod endingEPSGrowthEPS (basic)
TTM30 Sept 202630.81+50.73%30.89
FY202531 Dec 202522.95+95.99%23.07
FY202431 Dec 202411.71+101.90%11.76
FY202331 Dec 20235.80-15.94%5.83
FY202231 Dec 20226.90+12.75%6.57
FY202131 Dec 20216.12-5.41%5.85
FY202031 Dec 20206.47-25.55%6.47
FY201931 Dec 20198.69+177.64%8.69
FY201831 Dec 20183.13—3.14
FY201731 Dec 2017-0.19-107.63%-0.19
FY201631 Dec 20162.49+14.22%2.49
FY201531 Dec 20152.18+1.40%2.18
FY201431 Dec 20142.15-48.69%2.15
FY201331 Dec 20134.19+17.37%4.19
FY201231 Dec 20123.57-8.46%3.57
FY201131 Dec 20113.90-14.85%3.90
FY201031 Dec 20104.58+16.24%4.58
FY200931 Dec 20093.94—3.94
FY200831 Dec 2008-1.89-169.74%-1.89
FY200731 Dec 20072.71+10.61%2.71
FY200631 Dec 20062.45+35.36%2.45
FY200531 Dec 20051.81+9.04%1.82
FY200431 Dec 20041.66-29.96%1.67
FY200331 Dec 20032.37-5.20%2.38
FY200231 Dec 20022.50-1.96%2.51
FY200131 Dec 20012.55-8.60%2.58
FY200031 Dec 20002.79+13.41%2.83
FY199931 Dec 19992.46+31.55%2.50
FY199831 Dec 19981.87—1.91
FY199731 Dec 1997-0.34-125.00%-0.35
FY199631 Dec 19961.36-32.67%1.39
FY199531 Dec 19952.02+81.98%2.02
FY199431 Dec 19941.11+177.50%1.11
FY199331 Dec 19930.40-34.43%0.40
FY199231 Dec 19920.61-46.02%0.61
FY199131 Dec 19911.13+15.31%1.13
FY199031 Dec 19900.98+22.50%0.98
FY198931 Dec 19890.80+19.40%0.80
FY198831 Dec 19880.67+19.64%0.67
FY198731 Dec 19870.56+9.80%0.56
FY198631 Dec 19860.51+8.51%0.51
FY198531 Dec 19850.47—0.47

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Eli Lilly & Co's EPS

Source: Financial Modeling Prep